ECSP003775A - INTEGRIN ALFA V RECEIVER ANTAGONISTS - Google Patents
INTEGRIN ALFA V RECEIVER ANTAGONISTSInfo
- Publication number
- ECSP003775A ECSP003775A ECSP003775A ECSP003775A EC SP003775 A ECSP003775 A EC SP003775A EC SP003775 A ECSP003775 A EC SP003775A EC SP003775 A ECSP003775 A EC SP003775A
- Authority
- EC
- Ecuador
- Prior art keywords
- alphav
- antagonists
- present
- integrin
- inhibiting
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 102000006495 integrins Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 229940127449 Integrin Receptor Antagonists Drugs 0.000 abstract 1
- 108010040765 Integrin alphaV Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 108010045077 integrin alphaVbeta5 Proteins 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 206010061289 metastatic neoplasm Diseases 0.000 abstract 1
- 150000002842 nonanoic acids Chemical class 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a derivados novedosos de ácido nonanoico, su síntesis, y su uso como antagonistas del receptor de integrina alfaV. Más particularmente, los compuestos de la presente invención son antagonistas de los receptores integrina alfaV beta3 y alfaV beta5 y son útiles para inhibir la resorción ósea, tratar y prevenir osteoporosis, e inhibir restenosis vascular, retinopatía diabética, degeneración macular, angiogenesis, ateroesclerosis, inflamación, artritis inflamatoria, enfermedad viral, cáncer y crecimiento de tumor metastásico.The present invention relates to novel nonanoic acid derivatives, their synthesis, and their use as alphaV integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the alphaV beta3 and alphaV beta5 integrin receptors and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation , inflammatory arthritis, viral disease, cancer and metastatic tumor growth.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003775 ECSP003775A (en) | 2000-11-17 | 2000-11-17 | INTEGRIN ALFA V RECEIVER ANTAGONISTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003775 ECSP003775A (en) | 2000-11-17 | 2000-11-17 | INTEGRIN ALFA V RECEIVER ANTAGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003775A true ECSP003775A (en) | 2001-08-27 |
Family
ID=42041343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003775 ECSP003775A (en) | 2000-11-17 | 2000-11-17 | INTEGRIN ALFA V RECEIVER ANTAGONISTS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003775A (en) |
-
2000
- 2000-11-17 EC ECSP003775 patent/ECSP003775A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1187592T3 (en) | Alpha v integrin receptor antagonists | |
| DK1040111T3 (en) | Integrin receptor antagonists | |
| DE69829996D1 (en) | Integrin receptor Antagonist | |
| ATE236626T1 (en) | INTEGRIN ANTAGONIST | |
| DE69830806D1 (en) | INTEGRIN RECEPTOR ANTAGONISTS | |
| DE60126496D1 (en) | ALPHA V INTEGRIN RECEPTOR ANTAGONISTS | |
| ECSP003775A (en) | INTEGRIN ALFA V RECEIVER ANTAGONISTS | |
| ATE320258T1 (en) | DIBENZOXAZEPINE ALPHA V INTEGRIN RECEPTOR ANTAGONIST | |
| ECSP992897A (en) | INTEGRIN RECEPTOR ANTAGONISTS | |
| YU38200A (en) | Integrin receptor antagonists | |
| YU38300A (en) | Integrin receptor antagonists |